Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on June 03, 2019, 03:12:57 pm
-
The risk of cardiovascular disease (CVD) among people with hepatitis C virus (HCV) rises as their liver fibrosis (scarring) worsens. Treating the virus helps mitigate this risk.
Presenting their findings at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, researchers studied data on veterans from the ERCHIVES cohort. They assembled a cohort of 32,575 people with HCV who had received more than seven weeks of treatment for the virus. They matched this cohort with a group of the same size including people with untreated hep C.
Read more...
https://www.hepmag.com/article/heart-disease-risk-people-hep-c-elevates-fibrosis-worsens